Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04286308 · ClinicalTrials.gov registry record · NA

Cortical-Basal Ganglia Speech Networks

A NA study of Parkinson Disease and Essential Tremor, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04286308 is a NA study of Parkinson Disease and Essential Tremor that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04286308, a NA study of Parkinson Disease and Essential Tremor, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

In this research study the researchers want to learn more about brain activity related to speech perception and production.

Interventions

  • OTHER electrophysiological data collection

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2020-10-01
Est. Completion 2026-02
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04286308

The ClinicalTrials.gov registry entry for NCT04286308 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which electrophysiological data collection is the first listed.

NCT04286308 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04286308 about?

NCT04286308 is a clinical study titled "Cortical-Basal Ganglia Speech Networks". In this research study the researchers want to learn more about brain activity related to speech perception and production.

What is the current status of trial NCT04286308?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2020-10-01. Estimated completion is 2026-02.

What conditions does trial NCT04286308 study?

This clinical trial studies the following conditions: Parkinson Disease, Essential Tremor, Dystonia.

What interventions are being tested in trial NCT04286308?

The interventions under investigation include: electrophysiological data collection (OTHER).

Who is sponsoring clinical trial NCT04286308?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04286308 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.